Home/Clexio Biosciences/Orly Eini

OE

Orly Eini

VP HR

Clexio Biosciences

Therapeutic Areas

Major Depressive Disorder Epilepsy

Clexio Biosciences Pipeline

Drug	Indication	Phase
CLE-100	Major Depressive Disorder	Phase 2
CLE-043	Epilepsy and Major Depressive Disorder	Preclinical

Leadership Team at Clexio Biosciences

Elisabeth Kogan

CEO & Co‑Founder

Menashe Levy, Ph.D.

CTO & Co‑Founder

CDO & Co‑Founder

Efrat Shalom‑Berensohn, LL.M., MBA

General Counsel

Esther Hagai, M.D., Ph.D.

Chief Medical Officer

Martin Himmel, M.D., MPH

VP Business Development

VP Business Development

VP Business Development

Eran Nadav, Ph.D., MBA

VP Business Development

View full Clexio Biosciences profile